OBJECTIVES: To investigate how circulating leptin concentrations are related to regional fat distribution and whether moderate weight loss alters these relationships. DESIGN: A 6 month, clinical weight reduction trial with measurements before and after weight loss. SUBJECTS: 38 healthy, obese women (age: 44.3 AE 9.9 y, BMI: 34.0 AE 4.0 kgam 2 ). MEASUREMENTS: The following measurements were made. 1. indices of obesity and fat distribution: weight, body mass index (BMI), hip circumference (peripheral fat), waist circumference, total body fat (bioelectrical impedance), abdominal fat distribution: visceral fat and abdominal subcutaneous fat (ultrasonography); and 2. Biochemical measurements: plasma leptin and serum insulin. RESULTS: Baseline plasma leptin concentrations were three-fold higher in obese women than in normal weight controls. After weight loss averaging 8.4 kg (9.0 %), plasma leptin decreased by a mean of 22.3 % (P`0.001), corresponding to body fat decrease of 16.6% (P`0.001), abdominal subcutaneous fat decrease of 17.4% (P`0.001) and visceral fat decrease of 18.7% (P`0.001). The total amount of body fat correlated with plasma (serum) leptin before (r 0.64, P`0.001) and after (r 0.75, P`0.001) weight loss. Plasma leptin concentrations expressed per kg of body fat did not change signi®cantly during weight loss. After controlling for body fat, baseline leptin concentrations were signi®cantly associated with hip circumference (r 0.57, P`0.001) but not with any indices of abdominal fat distribution. After weight loss the associations became signi®cant for hip and waist circumference as well as for visceral and abdominal subcutaneous fat. Changes in leptin correlated with changes in all indices of obesity except visceral fat. CONCLUSIONS: Plasma leptin concentrations re¯ect not only total fat mass but also adipose tissue distribution, especially peripheral fat. Plasma leptin values per kilogram of fat mass do not change signi®cantly with modest weight loss.
Introduction
Leptin is a recently characterized protein secreted by adipocytes. 1 Circulating concentrations correlate with fat mass both in normal weight and obese subjects, 2 ± 4 and decline with weight loss. 3 ± 5 Whether weight reduction alters the relationship between adiposity and increased leptin concentrations is still controversial. 6, 7 Leptin concentrations vary widely at a given level of body fat suggesting that other factors such as adipose tissue distribution may also be involved. 3 Studies relating abdominal fat distribution to plasma leptin have yielded controversial results. Some studies show a strong association between visceral fat and circulating leptin concentration 8 or between omental fat cells and OB mRNA expression. 9 Other studies have demonstrated higher leptin expression in abdominal subcutaneous adipose tissue than in omental, retroperitoneal and mesenteric fat depots. 2, 10 Furthermore, peripheral fat may also be an important determinant of plasma leptin concentrations. 11 ± 13 However, it has been suggested that circulating leptin concentrations are not regulated by regional body fat distribution at all. 14 The aim of this study was to determine whether weight loss alters the relation between adiposity and increased plasma leptin concentrations. In addition, we analysed simultaneously the relation of plasma leptin to abdominal visceral and subcutaneous fat and to peripheral fat (gluteal femoral fat) before and after weight loss.
Materials and methods

Subjects and study design
The study subjects were 38 healthy, overweight women (body mass index (BMI) 34.0 AE 4.0 kgam 2 , age 44.3AE 9.9 y). They were participating in a 6 month clinical weight reduction trial using a hypocaloric, low fat diet with or without orlistat. Women with known diabetes, uncontrolled hypertension, signi®cant medical diseases and eating disorders were excluded. Written consent was obtained from all subjects after a detailed explanation of the study protocol. The study was approved by the Ethical Committee of the Helsinki University Central Hospital.
All measurements were performed after an overnight fast at the beginning of the study and were repeated after the six month treatment.
The controls for leptin determinations were 17 age-matched healthy, normal weight women. Their average age was 41AE 6.7 y and the mean BMI 24AE 4.5 kgam 2 .
Indexes of obesity
Weight was measured to the nearest 0.1 kg using an electronic scale (Vogle&Halke Gmb&Co, Germany) and height was measured to the nearest 0.1 cm. Waist circumference, a measure of total abdominal fat, was measured at the level midway between the lateral lower rib margin and iliac crest. Hip circumference, a measure of peripheral fat, was measured at the levels of the trochanters in the standing position. The body fat was determined using bioelectrical impedance analysis (BioElectrical Impedance Analyzer System, RJL Systems, Detroit, MI).
Ultrasound measurements
The ultrasound measurements were performed using Toshiba Sonolayer 100 A scanner with a 3.5 MHz convex transducer for determining visceral fat and a 7.5 MHz transducer (Toshiba Medical Co., Tokyo, Japan) for determining subcutaneous fat. Compression was carefully avoided. The error in identi®cation of structures and measurements of the depth was diminished by checking the copies afterwards by a highly trained operator. The measurements were performed at the level midway between the umbilicus and xiphoid process, which relates well to both total intraperitoneal and total abdominal subcutaneous fat. 15 The measurements were carried out by the method developed by Armellini et al. 16 The distance between the linea alba and the dorsal border of the abdominal aorta was an estimate of visceral fat. The thickness of the subcutis in the same sagittal line was a measure of abdominal subcutaneous fat. Our previous data showed a signi®cant association (r 0.77) between the ultrasonography measured visceral fat and CT measured visceral fat (unpublished data).
Biochemical analyses
Plasma leptin was measured by a human leptin radioimmunoassay (Human Leptin RIA kit, Linco Research Inc., St. Charles, MO). 17 Serum insulin was determined by a radioimmunoassay with a double antibody-PEG technique CIS (CIS biointernational, B.P. 32, F-91192, Git-sur-Yvette Codex, France). Serum follicle stimulating hormone (FSH) levels of the women who were aged ! 45 at baseline (n 21) were determined at baseline and at the end of the study using an immuno¯uorometric method (AutoDEFIA hFSH kit, Wallac Oy, Turku, Finland).
Younger women with regular menses were considered to be premenopausal (n 17). Using the cut point of 30 IUaI, nine women were considered to be postmenopausal, eight were premenopausal, and four were perimenopausal (FSH-values`30 IUaI at the beginning and ! 30 IUaI at the end). Therefore, altogether 25 women were premenopausal and 9 women postmenopausal.
Statistical analyses
Standard statistical tests including paired samples ttest and one-way analysis of variance were used. Partial Pearson correlation coef®cients were calculated to quantify the relation between leptin and different variables. All calculations were made using the SPSS-X statistical package. 18 Data are expressed as mean AE standard deviation (sd). P-values`0.05 were considered to be statistically signi®cant.
Results
During the weight loss, the mean percentage reduction of weight was 9.0% (8.4 kg) and 16.6% of total fat (Table 1) . Hip circumference (a surrogate measure of peripheral fat) as well as waist circumference (a measure of total abdominal fat) were reduced on an average by 5.8% and 6.9%, respectively. The amounts of abdominal subcutaneous fat and visceral fat declined by 17.4% and 18.7%, respectively.
Obese women had almost three-fold higher serum insulin concentrations (90.2 AE 45.7 pmolal) than normal weight control women (36.0 AE 17.0 pmolal) (Table 2) . Plasma leptin concentrations expressed per kg of body fat did not change signi®cantly.
As plasma leptin was signi®cantly correlated with body fat percentage both before (r 0.64, P`0.001) and after (r 0.75, P`0.001) weight loss, the association of leptin with different fat depots was studied after controlling for total fat. Unlike waist circumference, visceral and abdominal subcutaneous fat, hip circumference was signi®cantly related to plasma leptin before weight reduction (Figure 1 ). After weight loss both hip and waist circumference and abdominal fat depots correlated signi®cantly with plasma leptin. Waist-to-hip ratio was not related to plasma leptin either before or after weight loss. Difference before vs after weight loss, *P`0.05; **P`0.01; ***P`0.001.
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The association between plasma leptin and serum insulin concentrations became signi®cant (r 0.46, P`0.01) after weight reduction independently from body fat (data not shown).
Changes in circulating leptin concentrations during the weight loss correlated with changes in BMl (r 0.65), weight (r 0.67) and body fat (r 0.59) after adjusting for initial total fat (Table 3 ). In addition, changes in leptin concentration also correlated with changes in hip and waist circumferences as well as in abdominal subcutaneous fat. Similarly, changes in serum insulin related to plasma leptin.
Discussion
As far as we are aware, this is the ®rst study to address the relation of plasma leptin concentrations to both abdominal fat distribution and peripheral fat (hip girth) in moderately obese women. We observed a signi®cant relationship between circulating leptin concentrations and peripheral fat after adjusting for total body fat. A similar relationship was not observed for leptin and abdominal fat before weight reduction. After an average weight loss of 8.4 kg circulating leptin appeared to be associated with the amounts of all measured adipose depots.
Weight loss did not signi®cantly alter the amount of circulating leptin relative to total fat stores. Plasma leptin and body fat remained highly correlated after weight loss. Therefore, leptin concentrations declined proportionally with decreasing body fat in persons who still were overweight. Our result agrees with the observation of Almeras et al, 6 but not with the results of Wadden et al. 7 In the latter study, strict energy restriction (800 or 1200 ± 1500 kcalad) was applied during the ®rst 12 weeks resulting in greater decrease in plasma leptin at the beginning of the study than during the last 28 weeks. Leptin responds rapidly to short-term decreases of energy intake without any changes in fat mass. This can also be seen in fasting states. 19, 20 Peripheral fat has been recently reported to be an important regulator of fasting plasma leptin in massively obese subjects. 11 The positive relationship between plasma leptin and hip girth observed in our study and in that of Niskanen et al. 13 extends these ®ndings to moderately obese women. The underlying mechanism is unknown. The strong relationship between circulating leptin and hip circumference may be associated with the low rate of lipolysis due to decreased total number of b-adrenergic receptors in femoral fat cells and the strong antilipolytic effect of insulin in the subcutaneous femoralagluteal region. 21, 22 After weight loss both abdominal fat depots and peripheral adipose depot were signi®cantly related to plasma leptin concentrations. The association was weakest for visceral fat, intermediate for the abdominal subcutaneous region and highest for the subcutaneous femoralagluteal region. Our results are in concordance with recent studies showing a weaker association of circulating leptin with visceral fat than with abdominal subcutaneous fat. 10, 23 The differences between the relation of circulating leptin with abdominal subcutaneous fat and with visceral fat may be attributed to the amount of adipose tissue leptin mRNA, which varies from abdominal fat depot to another. 2, 24, 25 To our knowledge, OB mRNA expression in gluteal femoral area has not been analyzed and compared to circulating leptin concentrations.
Changes in fat distribution, especially in peripheral fat (hip girth) and in abdominal subcutaneous fat correlated signi®cantly with changes in circulating leptin. However, our results indicate that the change in total fat is still the most important determinant of the change of circulating leptin. The relation between long-term changes in leptin with total fat was also reported by a recent study. 7 In addition to the amount of total body adipose tissue, the change in serum insulin concentrations seems to have a crucial effect on the change of plasma leptin concentrations. It should be noted that at the end of our study the correlation between plasma leptin and serum insulin emerged as statistically signi®cant like in the controls in the beginning of the study. This might suggest that insulin sensitivity has improved in the adipocytes.
Leptin concentrations were unaffected by menopausal status. Similar results were observed in the study where the reproductive status was determined by analyzing follicle-stimulating hormone concentrations. 26 Also in a study of Saad et al. 27 leptin concentrations of postmenopausal women did not differ from those of younger women indicating that oestrogen and progestrerone may not affect plasma leptin.
Although the leptin concentrations in the groups taking orlistat declined more than in the placebotreated group (data not shown), there was no consistent relationship between the doses of orlistat and change of leptin. Furthermore, the placebo recipients D, changes of variables in 6 months; *P`0.05; **P`0.01; *** P`0.001. Abbreviations otherwise as in Table 1 .
Weight loss, fat distribution and leptin in women P Rissanen et al and women receiving only 30 mg orlistat were very heterogeneous, the standard deviations of the changes of plasma leptin levels were even bigger than the mean changes of leptin concentrations. We cannot therefore exclude the possibility that orlistat would have an effect, but ®rm conclusions are not warranted on the basis of these data.
Conclusion
Modest weight loss does not signi®cantly alter the amount of circulating leptin relative to total fat stores. Therefore leptin concentrations declined proportionally with decreasing body fat suggesting that obesity may be attributable to central rather than peripheral resistance to leptin. In addition to total body fat, plasma leptin may also re¯ect adipose tissue distribution, especially peripheral fat.
